Atropos & Arcadia: Real-world Evidence

Arcadia has been integrated into the Atropos EvidenceTM Network, giving Arcadia's provider customers access to Atropos Health's evidence applications. By enabling timely, educated clinical decisions based on specific patient data, this cooperation supports comprehensive patient care and value-based performance. Atropos Health's Life Sciences users will also be able to use Arcadia's longitudinal study dataset for real-world evidence studies as a result of the collaboration.

Atropos Health CEO Dr. Brigham Hyde stressed the need of optimizing clinical decision-making for value-based care, emphasizing Atropos Health's commitment to offering robust, data-driven solutions. The impact of this relationship on healthcare organizations, according to Michael Meucci, President and CEO of Arcadia, will improve patient outcomes by providing access to clinical research findings.

This partnership follows the introduction of Geneva OSTM and ChatRWDTM by Atropos Health, two innovations aimed at expediting evidence gathering. Atropos Health's recent founding of the Life Sciences Advisory Board, comprising of leaders from prominent pharmaceutical companies, strengthens the company's position in the life sciences sector.

Customers can use Atropos Health's evidence-generation tools, which are incorporated into Geneva OS, to improve trial design, enrollment, and subgroup analysis by leveraging AlexandriaTM, a massive collection of research, and the CRAFT Emulation ToolkitTM. This toolset facilitates the development of proof at the same rapid pace as Atropos Health's solutions.

Read More - bit.ly/3NVw4Ur